n-methyl-3,4-methylenedioxyamphetamine has been researched along with sr 59230a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brutcher, RE; Caden, D; Mills, EM; Rusyniak, DE; Sprague, JE | 1 |
Bexis, S; Docherty, JR | 1 |
2 other study(ies) available for n-methyl-3,4-methylenedioxyamphetamine and sr 59230a
Article | Year |
---|---|
Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-3 Receptor Antagonists; Animals; Blood Urea Nitrogen; Body Temperature; Creatine Kinase; Drug Administration Schedule; Drug Therapy, Combination; Fever; Injections, Intraperitoneal; Injections, Subcutaneous; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prazosin; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Rhabdomyolysis; Time Factors | 2004 |
Role of alpha 1- and beta 3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouse.
Topics: Adrenergic beta-3 Receptor Antagonists; Animals; Body Temperature; Fever; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; N-Methyl-3,4-methylenedioxyamphetamine; Propanolamines; Protein Binding; Rats; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3 | 2009 |